Confounding effects of metformin on the human gut microbiome in Type 2 diabetes
Other text in scientific journal, 2016
Type 2 diabetes (T2D) is associated with dysbiosis of the gut microbiota, though diabetes treatment regimens, including metformin, may confound the results. Forslund et al. (2015) identify distinct disease and drug signatures and highlight the importance of adjusting for treatment when investigating how T2D influences the human gut microbiome.
Author
Adil Mardinoglu
Royal Institute of Technology (KTH)
Chalmers, Biology and Biological Engineering, Systems and Synthetic Biology
Jan Borén
University of Gothenburg
Ulf Smith
University of Gothenburg
Sahlgrenska University Hospital
Cell Metabolism
1550-4131 (ISSN) 19327420 (eISSN)
Vol. 23 1 10-12Subject Categories
Cell and Molecular Biology
DOI
10.1016/j.cmet.2015.12.012